title: Pharmacogenomic modeling in pancreatic cancer—letter.
authors.affiliation: Molecular Medicine Group, Department of Modern Sciences and Technologies and Biochemistry of Nutrition Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Department of Medical Oncology, VU University Medical Center Amsterdam, Amsterdam, the Netherlands. a.avan@vumc.nl amir_avan@yahoo.com.
authors.forename: Amir
authors.initials: A
authors.lastname: Avan
authors.affiliation: Department of Medical Oncology, VU University Medical Center Amsterdam, Amsterdam, the Netherlands.
authors.forename: Abolfazl
authors.initials: A
authors.lastname: Avan
authors.affiliation: Department of Medical Oncology, VU University Medical Center Amsterdam, Amsterdam, the Netherlands.
authors.forename: Mina
authors.initials: M
authors.lastname: Maftouh
authors.affiliation: Molecular Medicine Group, Department of Modern Sciences and Technologies and Biochemistry of Nutrition Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Brighton and Sussex Medical School, Division of Medical Education, Falmer, Brighton, United Kingdom.
authors.forename: Majid Ghayour
authors.initials: MG
authors.lastname: Mobarhan
authors.affiliation: Institute of Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, California.
authors.forename: Sharareh
authors.initials: S
authors.lastname: Gholamin
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D019008:Drug Resistance, Neoplasm / Q000235:genetics*; D005260:Female; D006801:Humans; D008297:Male; D008954:Models, Biological; D009360:Neoplastic Cells, Circulating / Q000378:metabolism*; D010190:Pancreatic Neoplasms / Q000188:drug therapy* / Q000235:genetics*; D010597:Pharmacogenetics
chemical_list: D000970:Antineoplastic Agents